The in vitro antiprotozoal activities of crude methanolic extracts from the aerial parts of five Lamiaceae plants (Salvia tomentosa, S. sclarea, S. dichroantha, Nepeta nuda subsp. nuda and Marrubium astracanicum subsp. macrodon) were evaluated against four parasitic protozoa, i.e. Trypanosoma brucei rhodesiense, T. cruzi, Leishmania donovani and Plasmodium falciparum. The cytotoxic potentials of the extracts on L6 cells were also evaluated. Melarsoprol, benznidazole, miltefosine, chloroquine and podophyllotoxin were used as reference drugs. All crude MeOH extracts showed antiprotozoal potential against at least three parasites, so they were dispersed in water and partitioned against n-hexane and chloroform to yield three subextracts that were screened in the same test systems. The n-hexane extract of N. nuda was the most active against T. brucei rhodesiense while the CHCl 3 extracts of S. tomentosa and S. dichroantha showed significant activity against L. donovani. All organic extracts displayed in vitro antimalarial and moderate trypanocidal activities against T. cruzi with the n-hexane extract of S. sclarea being the most active against the latter. The extracts displayed low or no cytotoxicity towards mammalian L6 cells.
Tropical neglected diseases, i.e. African trypanosomiasis, Chagas disease, visceral leishmaniasis and malaria continue to be major health problems that affect millions of people worldwide. T. brucei rhodesiense, T. cruzi, Leishmania donovani, Plasmodium falciparum are the causative agents of these illnesses respectively [1a] . African trypanosomiasis, more commonly known as sleeping sickness, is caused by single-celled protozoa from the Trypanosoma genus. One of the two major species that infect humans is Trypanosoma brucei rhodesiense. The disease is limited to Africa, and outbreaks tend to affect isolated rural areas. Around 12,000 new cases were reported in 2006 [1b] . Chagas' disease (American trypanasomiasis) is an indigenous disease of 22 countries in the Western Hemisphere caused by the protozoa Trypanosoma cruzi [1c,2] . It has been estimated that there are 15-17 million people infected by T. cruzi in Latin America and 90-100 million are exposed to infection [3] . Leishmaniasis is caused by obligate intracellular and kinetoplastid protozoa of the genus Leishmania that is endemic to 88 countries with 350 million people at risk of infection [4a] . Parallel infections with diseases such as malaria and pneumonia increases the fatality of the illness, as do parallel infections of AIDS and the development of drug-resistance by the parasites [4b]. Visceral leishmaniasis, also known as kala-azar, is caused by Leishmania donovani [4c] . Malaria infects 300-500 million people and kills over 1 million people annually. Human malaria is endemic to 90 countries and is caused by the protozoa Plasmodium falciparum [4d].
The Lamiaceae family of mostly medicinal and aromatic plants is represented by around 3000 species in 250 genera worldwide. Turkish flora contains 558 species and 45 genera belonging to the Lamiaceae, almost half of which are endemic [5a] . Salvia (sage), the largest genus with 900 species worldwide [5b] and 90 in Turkey is commonly known as "adaçayı" [5a] . It is traditionally used as herbal tea with carminative, spasmolytic, diuretic, antiseptic and wound healing properties, as well as against rheumatic and abdominal pains, cold and cough [5c-5e]. In South African traditional medicine, some Salvia species are reported to treat fever and febrile attacks [6] . In vitro antiplasmodial activities of several Salvia species against Plasmodium falciparum were also reported [7,8a] . The genus Nepeta is represented by 33 species in Turkish flora and half of these species are endemic [5a] and used in traditional medicine to treat bronchitis [8b]. The genus Marrubium consists of perennial herbs of which 18 species grow in Turkey [5a] . Some species are used to treat bronchitis, cough, fever and asthma in folk medicine [9,10a] . Promising anti-microbial activity of M. vulgare extracts against Gram-positive bacteria was reported [10b]. As part of the systematic survey of the antiprotozoal activities of Turkish medicinal plants [10c,11a,11b] this study describes the in vitro antimalarial, trypanocidal, leishmanicidal and the cytotoxic activities of extracts of five Lamiaceae herbs of the genera Salvia, Nepeta and Marrubium native to Turkey.
In order to evaluate their in vitro antiprotozoal activity, the crude methanolic extracts of Salvia tomentosa, S. sclarea, S. dichroantha, Nepeta nuda subsp. nuda and Marrubium astracanicum subsp. Macrodon) were tested in vitro against four parasitic protozoa, Trypanosoma brucei rhodesiense, T. cruzi, Leishmania donovani and Plasmodium falciparum. The extracts were simultaneously tested on rat skeletal myoblasts (L6 cells) in order to determine their selectivity. Table 1 shows the results. All crude MeOH extracts displayed antiprotozoal potential against at least three parasites without any cytotoxicity. This includes trypanocidal activity against T. brucei rhodesiense with the extracts of N. nuda (Nn-MeOH), S. dichroantha (Sd-MeOH) and S. sclarea (Ss-MeOH) being the most potent, antileishmanial activity against L. donovani amastigotes, with Sd-MeOH showing the highest activity, and antiplasmodial activity with the extracts of Marrubium astracanicum subsp. macrodon (Ma-MeOH) and Ss-MeOH displaying the highest activity. On the contrary, all MeOH extracts were inactive against T. cruzi except for S. sclarea, which had mild activity. Remarkably, only the S. sclarea MeOH extract showed a marginal cytotoxicity against mammalian cells.
The crude MeOH extracts were dispersed in H 2 O and partitioned first against n-hexane, and then against CHCl 3 . All three subextracts (n-hexane, CHCl 3 and H 2 O) were screened as shown in Table 1 . All organic extracts showed antiprotozoal activity in varying degrees. Against T. brucei rhodesiense, the n-hexane extract of N. nuda (Nn-Hexane) showed very significant activity followed by the n-hexane (St-Hexane) and CHCl 3 extracts (St-CHCl 3 ) of S. tomentosa and the n-hexane extract of S. sclarea (Ss-Hexane). Interestingly, all aqueous extracts displayed trypanocidal potential with the water subextract of S. dichroantha (Sd-H 2 O) being the most active and the water subextract of Marrubium astracanicum subsp. macrodon (Ma-H 2 O) being the least active. Against the American trypanosomes (T. cruzi), all organic extracts were only moderately active whereas all aqueous subextracts were inactive.
All n-hexane and chloroform extracts had antileishmanial activity. The CHCl 3 -and n-hexane-solubles of S. tomentosa (St-CHCl 3 and St-Hexane) and the CHCl 3solubles of S. dichroantha (Sd-CHCl 3 ) exhibited the most significant activity against L. donovani.
A similar bioactivity profile was apparent against the drug resistant malaria parasite P. falciparum, where all organic extracts were quite active and H 2 O extracts were not. The CHCl 3 extracts of S. sclarea and N. nuda were the most potent.
When tested against mammalian L6 cells, only the organic extracts of S. tomentosa, the n-hexane extract of S. sclarea and the CHCl 3 extract of N. nuda showed cytotoxicity. The remaining extracts had marginal or no toxicity at the highest test concentrations (IC 50 s>90 µg/mL). In summary, the organic extracts were generally the most potent probably due to enrichment of more lipophilic compounds. Overall T. brucei rhodesiense appears to be the most susceptible protozoan species and with the subg/mL level activity and almost no toxicity on mammalian cells, the hexane extract of N. nuda is very promising. With a selectivity index (=therapeutic index, calculated by dividing the IC 50 value against L6 cells / the IC 50 value against parasite) of 137, this extract clearly merits further activity-guided isolation studies which are currently underway in our laboratory. In general, the hexane subextracts had a higher activity than the CHCl 3 extracts against both Trypanosoma species. The organic subextracts, in particular the CHCl 3 extracts proved to have good leishmanicidal and antiplasmodial properties. All three Salvia species investigated have remarkable antiprotozoal potential with S. dichroantha the most promising in terms of low toxicity profile. Despite the fact that only one Marrubium species was studied, M. astracanicum subsp. macrodon seems to be worthy of further chemical and biological studies, particularly for antiplasmodial activity. In vitro assay for Plasmodium falciparum: In vitro activity against erythrocytic stages of P. falciparum was determined by a modified [ 3 H]-hypoxanthine incorporation assay, using the chloroquine-and pyrimethamine-resistant K1 strain and the standard drug chloroquine. Briefly, parasite cultures incubated in RPMI 1640 medium with 5% Albumax (without hypoxanthine) were exposed to serial drug dilutions in microtiter plates. After 48 h of incubation at 37°C in a reduced oxygen atmosphere, 0.5 Ci 3 H-hypoxanthine was added to each well. Cultures were incubated for a further 24 h before they were harvested onto glass-fiber filters and washed with distilled water. The radioactivity was counted using a Betaplate TM liquid scintillation counter (Wallac, Zurich, Switzerland). The results were recorded as counts per minute (CPM) per well at each drug concentration and expressed as percentage of the untreated controls. IC 50 values were calculated from the sigmoidal inhibition curves using Microsoft Excel.
In vitro assay for Trypanosoma brucei rhodesiense: T. b. rhodesiense, STIB 900 strain, and the standard drug, melarsoprol, were used for the assay. This stock was isolated in 1982 from a human patient in Tanzania and after several mouse passages cloned and adapted to axenic culture conditions. Minimum Essential Medium (50 µL In vitro assay for Leishmania donovani: Amastigotes of L. donovani strain MHOM/ET/67/L82 were grown in axenic culture at 37°C in SM medium at pH 5.4 supplemented with 10% heat-inactivated fetal bovine serum under an atmosphere of 5% CO 2 in air. One hundred microlitres of culture medium with 10 5 amastigotes from axenic culture with or without a serial drug dilution were seeded in 96-well microtitre plates. Serial drug dilutions were prepared. After 72 h of incubation the plates were inspected under an inverted microscope to assure growth of the controls and sterile conditions. Alamar Blue (10 μL; 12.5 mg resazurin dissolved in 100 ml distilled water) were then added to each well and the plates incubated for another 2 h. Then the plates were read with a Spectramax Gemini XS microplate fluorometer using an excitation wavelength of 536 nm and an emission wavelength of 588 nm. Data were analyzed using the software Softmax Pro (Molecular Devices Cooperation, Sunnyvale, CA, USA). Decrease of fluorescence (= inhibition) was expressed as percentage of the fluorescence of control cultures and plotted against the drug concentrations. From the sigmoidal inhibition curves the IC 50 values were calculated. Miltefosine was used as a reference drug.
In vitro assay for cytotoxicity: Assays were performed in 96-well microtiter plates, each well containing 100 μL of RPMI 1640 medium supplemented with 1% L-glutamine (200 mM) and 10% fetal bovine serum, and 4 x 10 4 L6 cells (a primary cell line derived from rat skeletal myoblasts). Serial drug dilutions of seven 3-fold dilution steps covering a range from 90 to 0.123 μg/mL were prepared. After 72 h of incubation the plates were inspected under an inverted microscope to assure growth of the controls and sterile conditions. Alamar Blue (10 L, 12.5 mg resazurin dissolved in 100 ml double-distilled water) was then added to each well and the plates incubated for another 2 h. Then the plates were read with a Spectramax Gemini XS microplate fluorometer using an excitation wavelength of 536 nm and an emission wavelength of 588 nm. Data were analysed using the microplate reader software Softmax Pro. Podophyllotoxin was the standard drug used.
